HALO Jeffrey William Henderson sells $500K worth of shares
Jan 08, 2025, 5:32 AM
5.16%
What does HALO do
Halozyme Therapeutics, a San Diego-based biopharmaceutical company, specializes in drug delivery technology and has two proprietary products, Hylenex and XYOSTED, focusing on subcutaneous administration. Founded in 2003, it employs 373 people and partners with other firms for drug-device combinations.
Jeffrey William Henderson sold 10,000 shares of HALO on 6 January at $50.01 per share, worth a total of $500K. They now own 43,611 HALO shares, or a 19% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.